Antigen-armed antibodies against B-cell malignancies
Antigen-armed antibodies against B-cell malignancies |
|
https://doi.org/10.18632/oncotarget.26276
Marta Ilecka,
Dwain G. van Zyl,
and Henri-Jacques Delecluse
|
| 35601-35602 |
B2M, JAK2 and MET in the genetic landscape of immunotolerance in lung cancer
B2M, JAK2 and MET in the genetic landscape of immunotolerance in lung cancer |
|
https://doi.org/10.18632/oncotarget.26277
Montse Sanchez-Cespedes
|
| 35603-35604 |
Precision virotherapies: Coming soon
Precision virotherapies: Coming soon |
|
https://doi.org/10.18632/oncotarget.26280
Hanni Uusi-Kerttula,
and Alan L. Parker
|
| 35605-35606 |
Should we measure clonal circulating plasma cells in light chain amyloidosis?
Should we measure clonal circulating plasma cells in light chain amyloidosis? |
|
https://doi.org/10.18632/oncotarget.26289
Surbhi Sidana,
Shaji K. Kumar,
and Wilson I. Gonsalves
|
| 35607-35608 |
Aberrant glycosylation in colorectal cancer with genomic and epigenomic alterations
Aberrant glycosylation in colorectal cancer with genomic and epigenomic alterations |
|
https://doi.org/10.18632/oncotarget.26292
Hirokazu Okayama,
Masaru Noda,
and Koji Kono
|
| 35609-35610 |
Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution
Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution |
|
https://doi.org/10.18632/oncotarget.26242
Joshua N. Kellner,
Eveline M. Delemarre,
Eric Yvon,
Stefan Nierkens,
Jaap J. Boelens,
Ian McNiece,
Amanda Olson,
Yago Nieto,
Stefan Ciurea,
Uday Popat,
Sairah Ahmed,
Richard Champlin,
Jennifer Ramos,
Mitsutaka Nishimoto,
Hongbing Ma,
Zeng Ke,
Peter Thall,
Joseph D. Khoury,
Robert Negrin,
Borje Andersson,
and Simrit Parmar
|
| 35611-35622 |
Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer
Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer |
|
https://doi.org/10.18632/oncotarget.26256
Elena Fountzilas,
Vassiliki Kotoula,
Ioannis Tikas,
Kyriaki Manousou,
Kyriaki Papadopoulou,
Christos Poulios,
Vasilios Karavasilis,
Ioannis Efstratiou,
Dimitrios Pectasides,
Kleo Papaparaskeva,
Ioannis Varthalitis,
Christos Christodoulou,
George Papatsibas,
Sofia Chrisafi,
Georgios K. Glantzounis,
Amanda Psyrri,
Gerasimos Aravantinos,
Georgia-Angeliki Koliou,
George K. Koukoulis,
George E. Pentheroudakis,
and George Fountzilas
|
| 35623-35638 |
DVL1 and DVL3 differentially localize to CYP19A1 promoters and regulate aromatase mRNA in breast cancer cells
DVL1 and DVL3 differentially localize to CYP19A1 promoters and regulate aromatase mRNA in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.26257
Isabel Castro-Piedras,
Monica Sharma,
Meghan den Bakker,
Deborah Molehin,
Edgar G. Martinez,
David Vartak,
Wendy M. Pruitt,
Jena Deitrick,
Sharilyn Almodovar,
and Kevin Pruitt
|
| 35639-35654 |
Expression of neuropilin-1 is linked to glioma associated microglia and macrophages and correlates with unfavorable prognosis in high grade gliomas
Expression of neuropilin-1 is linked to glioma associated microglia and macrophages and correlates with unfavorable prognosis in high grade gliomas |
|
https://doi.org/10.18632/oncotarget.26273
Michael D. Caponegro,
Richard A. Moffitt,
and Stella E. Tsirka
|
| 35655-35665 |
Clinical associations of mucin 1 in human lung cancer and precancerous lesions
Clinical associations of mucin 1 in human lung cancer and precancerous lesions |
|
https://doi.org/10.18632/oncotarget.26278
Andreas Saltos,
Farah Khalil,
Michelle Smith,
Jiannong Li,
Michael Schell,
Scott J. Antonia,
and Jhanelle E. Gray
|
| 35666-35675 |
Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition
Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition |
|
https://doi.org/10.18632/oncotarget.26281
Douglas Spaeth-Cook,
Mark Burch,
Robin Belton,
Bryce Demoret,
Nicholas Grosenbacher,
Jason David,
Colin Stets,
David Cohen,
Reena Shakya,
John L. Hays,
and James L. Chen
|
| 35676-35686 |
A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study
A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study |
|
https://doi.org/10.18632/oncotarget.26286
Begoña Martin-Castillo,
Sonia Pernas,
Joan Dorca,
Isabel Álvarez,
Susana Martínez,
Jose Manuel Pérez-Garcia,
Norberto Batista-López,
César A. Rodríguez-Sánchez,
Kepa Amillano,
Severina Domínguez,
Maria Luque,
Agostina Stradella,
Idoia Morilla,
Gemma Viñas,
Javier Cortés,
Elisabet Cuyàs,
Sara Verdura,
Álvaro Fernández-Ochoa,
Salvador Fernández-Arroyo,
Antonio Segura-Carretero,
Jorge Joven,
Elsa Pérez,
Neus Bosch,
Margarita Garcia,
Eugeni López-Bonet,
Samiha Saidani,
Maria Buxó,
and Javier A. Menendez
|
| 35687-35704 |
EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients
EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients |
|
https://doi.org/10.18632/oncotarget.26298
Sanne de Wit,
Mariangela Manicone,
Elisabetta Rossi,
Rita Lampignano,
Liwen Yang,
Beate Zill,
Alvera Rengel-Puertas,
Marianne Ouhlen,
Mateus Crespo,
Anne Margreet Sofie Berghuis,
Kiki Carlijn Andree,
Riccardo Vidotto,
Elisabeth Katharina Trapp,
Marie Tzschaschel,
Emeline Colomba,
Gemma Fowler,
Penelope Flohr,
Pasquale Rescigno,
Mariane Sousa Fontes,
Rita Zamarchi,
Tanja Fehm,
Hans Neubauer,
Brigitte Rack,
Marianna Alunni-Fabbroni,
Françoise Farace,
Johann De Bono,
Maarten Joost IJzerman,
and Leonardus Wendelinus Mathias Marie Terstappen
|
| 35705-35716 |
